Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.

In models of human lung and head and neck cancer, there have been anecdotal reports of a bystander effect in wild-type p53 gene therapy, an apoptosis-inducing molecular intervention strategy. These reports do not definitively demonstrate the presence of a bystander effect, nor do they elucidate requirements for or characteristics of this phenomenon. We have investigated human squamous cell carcinoma of the head and neck for the presence and requirements of a bystander effect after wild-type p53 gene transduction. Recombinant adenovirus, Ad-p53, was used for wild-type p53 gene transfers. To investigate the role of intercellular contact between p53-transduced and nontransduced cells in mediating a growth inhibitory (bystander) effect on nontransduced cells, coculturing experiments were conducted on human squamous cell carcinoma of the head and neck cell lines TU138 and TU167. For TU138, 29% growth inhibition of nontransduced cells was demonstrated 3 days after p53-transduced and nontransduced cells were cocultured with intercellular contact. This growth inhibition was abolished when cells were cocultured without intercellular contact. TU167 did not demonstrate a bystander effect under any coculturing condition. Supernatant from Ad-p53-infected TU138 and TU167 cells demonstrated no growth-inhibitory effect on respective nontransduced cells. The bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of squamous cell carcinoma of the head and neck, when present, requires intercellular contact. Possible mechanisms of the observed in vitro bystander effect are discussed.

[1]  J. Pitts.  Cancer gene therapy: A bystander effect using the gap junctional pathway , 1994, Molecular carcinogenesis.

[2]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Sanderson,et al.  Intercellular calcium signaling via gap junctions in glioma cells , 1992, The Journal of cell biology.

[4]  C. Lo.  The role of gap junction membrane channels in development , 1996, Journal of bioenergetics and biomembranes.

[5]  M. Chalfie,et al.  Green fluorescent protein as a marker for gene expression. , 1994, Science.

[6]  B. L. Van Duuren,et al.  Phenotypic Expression of Transformation: Induction in Cell Culture by a Phorbol Ester , 1967, Science.

[7]  W. Hamel,et al.  Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. , 1996, Cancer research.

[8]  R. Warnick,et al.  In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. , 1993, Human gene therapy.

[9]  K. Willecke,et al.  Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Kuriyama,et al.  Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma , 1995, Hepatology.

[11]  E. Harley,et al.  Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. , 1986, Biochemical and biophysical research communications.

[12]  J. Roth,et al.  A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. , 1993, Cancer research.

[13]  A. Balmain,et al.  Cell‐cell communication and growth control of normal and cancer cells: Evidence and hypothesis , 1993 .

[14]  J. Barrett,et al.  Gap junction function and cancer. , 1993, Cancer research.

[15]  H. Yamasaki,et al.  Gap junctional intercellular communication and carcinogenesis. , 1990, Carcinogenesis.

[16]  S. Meylaerts,et al.  Bystander tumoricidal effect in the treatment of experimental brain tumors. , 1994, Neurosurgery.

[17]  J. Roth,et al.  Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. , 1994, Cancer research.

[18]  T. McDonnell,et al.  Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. , 1995, Cancer research.

[19]  Z. Hao,et al.  p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy , 1997, Oncogene.

[20]  J. Roth,et al.  Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. , 1993, Human gene therapy.

[21]  J. Connor,et al.  Hepatocyte gap junctions are permeable to the second messenger, inositol 1,4,5-trisphosphate, and to calcium ions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Appella,et al.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Hong,et al.  Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer. , 1996, Nature Medicine.

[24]  J. Roth,et al.  In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. , 1995, Cancer research.

[25]  J. Trosko,et al.  Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. , 1987, Experimental cell research.

[26]  L. Pavelic,et al.  HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect. , 1996, Archives of otolaryngology--head & neck surgery.

[27]  P. Ryan,et al.  Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". , 1995, Human gene therapy.

[28]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[29]  H. Yamasaki,et al.  A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. , 1997, Cancer research.